|
?:authorAffiliation
|
-
[\'Retroviral Immunology, London, United Kingdom.\', \'National Heart and Lung Institute, Imperial College London, London, United Kingdom.\', \'High Throughput Screening STP, London, United Kingdom.\', \'Worldwide Influenza Centre, London, United Kingdom.\', \'Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom.\', \'Division of Infection and Immunity, London, United Kingdom.\', \'RNA Virus Replication Laboratory, London, United Kingdom.\', \'Department of Population, Policy and Practice, London, United Kingdom.\', \'School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.\', \'KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.\', \'Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.\', \'Department of Global Health, University of Washington, Seattle, United States.\', \'Africa Health Research Institute, Durban, South Africa.\', \'Max Planck Institute for Infection Biology, Berlin, Germany.\', \'Structural Biology STP, London, United Kingdom.\', \'Cancer Evolution and Genome Instability Laboratory, London, United Kingdom.\', \'Neurodegradation Biology Laboratory, London, United Kingdom.\', \'Cell Biology of Infection Laboratory, London, United Kingdom.\', \'Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London, United Kingdom.\', \'Department of Infectious Disease, St Mary\'s Hospital, Imperial College London, London, United Kingdom.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}